INNOVATION1 BIOTECH INC.: current liabilities
Current liabilities for INNOVATION1 BIOTECH INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All INNOVATION1 BIOTECH INC. financial histories
What this measure means
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
Exact concept: us-gaap:LiabilitiesCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2017-08-31 to 2023-08-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2023-08-31 | 3,286,957 | USD | 2024-01-17 | 10-K · 0001477932-24-000223 |
| At date | 2022-08-31 | 29,812,416 | USD | 2024-01-17 | 10-K · 0001477932-24-000223 |
| At date | 2021-08-31 | 406,725 | USD | 2022-12-15 | 10-K · 0001477932-22-009309 |
| At date | 2020-08-31 | 2,886,610 | USD | 2021-12-10 | 10-K · 0001477932-21-009127 |
| At date | 2019-08-31 | 224,053 | USD | 2020-12-15 | 10-K · 0001477932-20-007273 |
| At date | 2018-08-31 | 686,868 | USD | 2019-12-17 | 10-K · 0001477932-19-007157 |
| At date | 2017-08-31 | 16,101 | USD | 2018-12-14 | 10-K · 0001477932-18-005998 |
Related financial histories
- INNOVATION1 BIOTECH INC.: total assets
- INNOVATION1 BIOTECH INC.: total liabilities
- INNOVATION1 BIOTECH INC.: stockholders equity
- INNOVATION1 BIOTECH INC.: cash and cash equivalents
- INNOVATION1 BIOTECH INC.: net income or loss
- INNOVATION1 BIOTECH INC.: operating cash flow
- INNOVATION1 BIOTECH INC.: capital expenditure payments
- INNOVATION1 BIOTECH INC.: revenue
- INNOVATION1 BIOTECH INC.: financing cash flow
- INNOVATION1 BIOTECH INC.: investing cash flow
- INNOVATION1 BIOTECH INC.: retained earnings or deficit
- INNOVATION1 BIOTECH INC.: basic weighted-average shares
- INNOVATION1 BIOTECH INC.: basic earnings per share
- INNOVATION1 BIOTECH INC.: net property, plant and equipment
- INNOVATION1 BIOTECH INC.: share-based compensation expense
- INNOVATION1 BIOTECH INC.: operating income or loss
- INNOVATION1 BIOTECH INC.: current assets
- INNOVATION1 BIOTECH INC.: interest expense
- INNOVATION1 BIOTECH INC.: current accounts payable
- INNOVATION1 BIOTECH INC.: net current accounts receivable
- INNOVATION1 BIOTECH INC.: common-stock repurchase payments
- INNOVATION1 BIOTECH INC.: operating expenses
- INNOVATION1 BIOTECH INC.: net inventory
- INNOVATION1 BIOTECH INC.: gross profit
- INNOVATION1 BIOTECH INC.: cost of revenue
- INNOVATION1 BIOTECH INC.: research and development expense
Inspect the source
- Entity
- INNOVATION1 BIOTECH INC. / CIK 0001629205
- Captured
- 2026-09-21T17:21:04.610Z
- SEC response SHA-256
c5f3acfa863971b33b185130c620366a2f45cfd805cf4850d8be9be21b48d8fb
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001629205.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))